Serum-soluble ST2 as a novel biomarker for COVID-19 severity and mortality: A systematic review and meta-analysis
Saved in:
Main Authors: | Kacper DZIEDZIC, Lukasz SZARPAK, Michal PRUC, Damian SWIECZKOWSKI, Gabriella NUCERA, Kavita BATRA, Hicham KHABBACHE, Mahmood BAHRAMIZADEH, Murat YILDRIM, Aldo SITIBONDO, Sagar GALWANKAR, Eryka KARBOWSKA, Krzysztof KUREK, Monika TOMASZEWSKA |
---|---|
Format: | Article |
Language: | English |
Published: |
Edizioni FS
2024-03-01
|
Series: | Journal of Health and Social Sciences |
Subjects: | |
Online Access: | https://journalhss.com/wp-content/uploads/JHSS_SRMS3.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic review and meta-analysis of the association between galectin-3 levels and clinical outcomes in COVID-19 patients
by: Kacper DZIEDZIC, et al.
Published: (2023-12-01) -
The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
by: Magdalena Dudek, et al.
Published: (2024-12-01) -
The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden
by: Elena Revuelta-López, et al.
Published: (2025-01-01) -
Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
by: Sandra Crnko, et al.
Published: (2020-06-01) -
The pathogenesis of COVID-19: Hypercoagulation and D-dimer in thrombotic complications
by: Leonid DUBEY, et al.
Published: (2023-03-01)